{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T11:20:09Z","timestamp":1789471209037,"version":"build-2803163510"},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100023961","name":"Centro de Investigaci\u00f3n Biotecnol\u00f3gica en Red de Enfermedades Infecciosas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023961","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002911","name":"Universidad Complutense de Madrid","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002911","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Public Health"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jiph.2025.103034","type":"journal-article","created":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T10:31:00Z","timestamp":1763029860000},"page":"103034","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Post-pandemic increase in pediatric invasive pneumococcal disease driven by serotype 3"],"prefix":"10.1016","volume":"19","author":[{"given":"Jorge","family":"Benito Arribas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celina","family":"Garc\u00eda P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia","family":"Cercenado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes","family":"Mar\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bego\u00f1a","family":"Santiago Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Luisa","family":"Navarro G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiph.2025.103034_bib1","unstructured":"Comit\u00e9 Asesor de Vacunas de la Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda (CAV-AEP). Recomendaciones de vacunaci\u00f3n frente al neumococo. Calendario de vacunaci\u00f3n infantil 2024. Available at \u3008https:\/\/vacunasaep.org\u3009 [last accessed: June 2025]."},{"key":"10.1016\/j.jiph.2025.103034_bib2","series-title":"En: Farreras-Rozman. Medicina Interna","first-page":"2101","article-title":"Infecciones neumoc\u00f3cicas","year":"2020"},{"issue":"4","key":"10.1016\/j.jiph.2025.103034_bib3","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S1695-4033(02)77931-9","article-title":"Estudio de la incidencia de enfermedad neumoc\u00f3cica invasora entre 0\u20135 a\u00f1os en el Pa\u00eds Vasco y Navarra","volume":"57","author":"Iturbe","year":"2002","journal-title":"Pedia (Barc)"},{"key":"10.1016\/j.jiph.2025.103034_bib4","series-title":"Tratado de Pediatr\u00eda","first-page":"786","article-title":"Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda","author":"Meningitis Bacteriana","year":"2014"},{"issue":"6","key":"10.1016\/j.jiph.2025.103034_bib5","first-page":"501","article-title":"Enfermedad Neumoc\u00f3cica Invasiva en Ni\u00f1os Menores de 60 Meses, antes y despu\u00e9s de la Introducci\u00f3n de la Vacuna Conjugada 13-valente. Invasive pneumococcal disease in children under 60 months before and after availability of 13-valent conjugate vaccine","volume":"96","author":"Mart\u00ednez-Osorio","year":"2022","journal-title":"Pedia (Engl Ed)"},{"key":"10.1016\/j.jiph.2025.103034_bib6","unstructured":"The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 14.0. 2024. Disponible en: \u3008https:\/\/www.eucast.org\u3009."},{"issue":"3","key":"10.1016\/j.jiph.2025.103034_bib7","doi-asserted-by":"crossref","first-page":"469","DOI":"10.17843\/rpmesp.2022.394.12054","article-title":"Enfermedad neumoc\u00f3cica invasiva en pacientes de un hospital pedi\u00e1trico de Per\u00fa, 2017\u20132020","volume":"39","author":"Mar\u00edn-Portocarrero","year":"2022","journal-title":"Rev Peru Med Exp Salud Publica"},{"issue":"1","key":"10.1016\/j.jiph.2025.103034_bib8","first-page":"8","article-title":"Resultados de la vigilancia de las enfermedades transmisibles notificadas a la Red Nacional de Vigilancia Epidemiol\u00f3gica (RENAVE) en 2021","volume":"31","author":"Amillategui Dos Santos","year":"2023","journal-title":"Bol Epidemiol Sem"},{"issue":"4","key":"10.1016\/j.jiph.2025.103034_bib9","first-page":"260","article-title":"Enfermedad Neumoc\u00f3cica Invasiva en Espa\u00f1a en 2022","volume":"31","author":"Soler-Soneira","year":"2023","journal-title":"Bol Epidemiol Sem"},{"issue":"11","key":"10.1016\/j.jiph.2025.103034_bib10","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.3390\/microorganisms9112286","article-title":"Age-Dependent serotype-associated case-fatality rate in invasive pneumococcal disease in the autonomous community of madrid between 2007 and 2020","volume":"9","author":"De Miguel","year":"2021","journal-title":"Microorganisms"},{"issue":"11","key":"10.1016\/j.jiph.2025.103034_bib11","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.3201\/eid2811.211741","article-title":"Effect of COVID-19 pandemic on invasive pneumococcal disease in children, Catalonia, Spain","volume":"28","author":"Ciruela","year":"2022","journal-title":"Emerg Infect Dis"},{"issue":"6","key":"10.1016\/j.jiph.2025.103034_bib12","doi-asserted-by":"crossref","first-page":"e360","DOI":"10.1016\/S2589-7500(21)00077-7","article-title":"Changes in invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis during the COVID-19 pandemic in 26 countries: a prospective analysis","volume":"3","author":"Brueggemann","year":"2021","journal-title":"Lancet Digit Health"},{"issue":"7","key":"10.1016\/j.jiph.2025.103034_bib13","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1093\/cid\/ciac100","article-title":"Re-emergence of invasive pneumococcal disease in Germany during spring and summer 2021","volume":"75","author":"Perniciaro","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.jiph.2025.103034_bib14","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.3201\/eid2808.220304","article-title":"Increased incidence of invasive pneumococcal disease among children after the COVID-19 pandemic, England","volume":"28","author":"Bertran","year":"2022","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"10.1016\/j.jiph.2025.103034_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2024.106242","volume":"89","author":"Silva-Costa","year":"2024","journal-title":"J Infect"},{"issue":"3","key":"10.1016\/j.jiph.2025.103034_bib16","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.anpedi.2023.01.001","article-title":"Cambios en la epidemiolog\u00eda de las infecciones en ni\u00f1os. \u00bfExiste la deuda inmunitaria?","volume":"98","author":"Calvo","year":"2023","journal-title":"Pedia (Barc)"},{"issue":"10","key":"10.1016\/j.jiph.2025.103034_bib17","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1097\/INF.0b013e31829be1bb","article-title":"Necrotizing pneumonia in children: report of 41 cases between 2006 and 2011 in a French tertiary care center","volume":"32","author":"Lema\u00eetre","year":"2013","journal-title":"Pedia Infect Dis J"},{"issue":"7","key":"10.1016\/j.jiph.2025.103034_bib18","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/INF.0000000000002633","article-title":"Clinical and epidemiological characteristics of necrotizing pneumonia in children: A multicenter study in Spain","volume":"39","author":"Blanco-Iglesias","year":"2020","journal-title":"Pedia Infect Dis J"},{"issue":"2","key":"10.1016\/j.jiph.2025.103034_bib19","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/cid\/cit721","article-title":"Seasonal drivers of pneumococcal disease incidence: impact of bacterial carriage and viral activity","volume":"58","author":"Weinberger","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"191","key":"10.1016\/j.jiph.2025.103034_bib20","article-title":"Live attenuated influenza vaccine enhances colonization of Streptococcus pneumoniae and Staphylococcus aureus in mice","volume":"5","author":"Mina","year":"2013","journal-title":"Sci Transl Med"},{"issue":"2","key":"10.1016\/j.jiph.2025.103034_bib21","first-page":"e588","article-title":"Decline in pneumococcal disease in young children during the COVID-19 pandemic in Israel associated with suppression of seasonal respiratory viruses, despite persistent pneumococcal carriage: a prospective cohort study","volume":"75","author":"Danino","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.jiph.2025.103034_bib22","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.3201\/eid2606.190951","article-title":"Failures of 13-valent conjugated pneumococcal vaccine in age-appropriately vaccinated children 2\u201359 months of age, Spain","volume":"26","author":"Hern\u00e1ndez","year":"2020","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"10.1016\/j.jiph.2025.103034_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2024.106204","article-title":"Surveillance of invasive pneumococcal disease in Spain exploring the impact of the COVID-19 pandemic (2019-2023)","volume":"89","author":"P\u00e9rez-Garc\u00eda","year":"2024","journal-title":"J Infect"},{"issue":"38","key":"10.1016\/j.jiph.2025.103034_bib24","doi-asserted-by":"crossref","first-page":"5486","DOI":"10.1016\/j.vaccine.2023.07.049","article-title":"Effectiveness of thirteen-valent pneumococcal conjugate vaccine to prevent serotype 3 invasive pneumococcal disease in Quebec in children, Canada","volume":"41","author":"Deceuninck","year":"2023","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.jiph.2025.103034_bib25","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1093\/infdis\/jiac376","article-title":"Nasopharyngeal carriage of pneumococcus in children in England up to 10 years after PCV13 introduction: persistence of serotypes 3 and 19A and emergence of 7C","volume":"227","author":"Tiley","year":"2023","journal-title":"J Infect Dis"},{"issue":"8","key":"10.1016\/j.jiph.2025.103034_bib26","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1097\/INF.0000000000002765","article-title":"A phase II trial of safety, tolerability and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, compared with 13-valent pneumococcal conjugate vaccine in healthy infants","volume":"39","author":"Platt","year":"2020","journal-title":"Pedia Infect Dis J"},{"issue":"10","key":"10.1016\/j.jiph.2025.103034_bib27","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1097\/INF.0000000000003277","article-title":"Safety and immunogenicity of a 20-valent pneumococcal conjugate vaccine in healthy infants in the United States","volume":"40","author":"Senders","year":"2021","journal-title":"Pedia Infect Dis J"}],"container-title":["Journal of Infection and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034125003831?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034125003831?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:11:47Z","timestamp":1785856307000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876034125003831"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S1876034125003831"],"URL":"https:\/\/doi.org\/10.1016\/j.jiph.2025.103034","relation":{},"ISSN":["1876-0341"],"issn-type":[{"value":"1876-0341","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Post-pandemic increase in pediatric invasive pneumococcal disease driven by serotype 3","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Public Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiph.2025.103034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences.","name":"copyright","label":"Copyright"}],"article-number":"103034"}}